Inovio Biomedical to Present at American Society of Gene Therapy Meeting
News May 31, 2007
Inovio Biomedical Corporation has announced that the company will make multiple presentations regarding its electroporation-mediated DNA delivery technology at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT) being held in Seattle, WA, May 30 - June 3 at the Washington State Trade and Convention Center.
Inovio's DNA delivery systems are designed to enhance the potency of DNA-based immunotherapies and vaccines against infectious diseases and cancers.
Three of the five poster presentations discuss pre-clinical studies that evaluated immune responses to DNA vaccines directed against major infectious diseases including malaria, HIV and hepatitis C.
In all cases Inovio's electroporation technology enhanced antibody and cellular immune responses when compared with traditional vaccine delivery methods. Two other Inovio presentations report innovations in the development of electroporation DNA delivery devices.
These presentations include: Immunogenicity of a Cytokine Enhanced Multi-Antigen pDNA Vaccine with and without In Vivo Electroporation in Rhesus Macaques.
As the world struggles to meet the increasing demand for energy, coupled with the rising levels of CO2 in the atmosphere from deforestation and the use of fossil fuels, photosynthesis in nature simply cannot keep up with the carbon cycle. In a recent paper, researchers report significant progress in optimizing systems that mimic the first stage of photosynthesis, capturing and harnessing light energy from the sun.